(Q50920944)

25 March 2018

title

Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. (English)

1 reference

25 March 2018

author name string

Brambilla F

1

1 reference

25 March 2018

Perna G

2

1 reference

25 March 2018

Bellodi L

3

1 reference

25 March 2018

Arancio C

4

1 reference

25 March 2018

Bertani A

5

1 reference

25 March 2018

Perini G

6

1 reference

25 March 2018

Carraro C

7

1 reference

25 March 2018

Gava F

8

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

25 March 2018

published in

Biological Psychiatry

1 reference

25 March 2018

volume

42

1 reference

25 March 2018

page(s)

976-981

1 reference

25 March 2018

issue

11

1 reference

25 March 2018

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Corticotropin releasing factor stimulation test in obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Intrahypothalamic infusion of interleukin-1 beta increases the release of corticotropin-releasing hormone (CRH 41) and adrenocorticotropic hormone (ACTH) in free-moving rats bearing a push-pull cannula in the median eminence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Immunoregulation mediated by the sympathetic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Psychoimmunoendocrine aspects of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Plasma interleukin-1 beta concentrations in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Noradrenergic receptor sensitivity in obsessive-compulsive disorders: I. growth hormone response to clonidine stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Systemic hormonal and physiological abnormalities in anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Obsessive-compulsive disorder and the DST

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Interaction between Norepinephrine and Serotonin in the Neuroendocrine Control of Growth Hormone Release in the Rat*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

A neuroanatomical hypothesis for panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Circadian variations in antigen-specific proliferation of human T lymphocytes and correlation to cortisol production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Modulation of cellular immunity in medical students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Nutritional aspects of leukocytic cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Dexamethasone suppression tests in patients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Immune Cell Imbalance in Major Depressive and Panic Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Interleukin-1 induces analgesia in mice by a central action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Abnormal diurnal variation of B lymphocyte circulation patterns in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Immunological response to stress in agoraphobia and panic attacks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Interleukin-1 receptors in mouse brain: characterization and neuronal localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

Reduced Cytokine Levels and T-Cell Function in Healthy Males: Relation to Individual Differences in Subclinical Anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900495-7

10.1016/S0006-3223(96)00495-7

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9386848

1 reference

25 March 2018